Present status and perspectives of cell-based therapies for liver diseases
Andreas K. Nüssler(BG Klinik Tübingen), Jan G. Hengstler(TU Dortmund University), Étienne Sokal(Cliniques Universitaires Saint-Luc), Bruno Christ(Fraunhofer Institute for Silicate Research), Michael Ott(Center for Experimental and Clinical Infection Research), G. Gäbelein(Charité - Universitätsmedizin Berlin), Michael Manns(Medizinische Hochschule Hannover), Maren Schulze, Wiebke Schormann(Leipzig University), Steven Strom(University of Pittsburgh), Ewa Ellis(Karolinska University Hospital), Matthias Kraemer(University of Münster), Wolfgang E. Thasler(LMU Klinikum), Wolfgang E. Fleig(University Hospital Leipzig), Frank Nocken(Neovii Biotech (Germany)), Sarah König(University of Göttingen), Marc Brulport(Leipzig University)
Cited by 205
Related Papers
De novo transcript sequence reconstruction from RNA-seq using the Trinity platform for reference generation and analysis
|Nature Protocols|2013|9.1k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis Based on Aggregate Data
|Journal of Clinical Oncology|2006|1.2k